Title: Impact of ‘‘Advance Patients Care Plan’’ in Cardiovascular Disorders

Authors: Dr Soumadip Das, Dr Rajat Rana, Dr Aravinda Swami, Dr C K Dhanapal, Dr K.K. Perumal

 DOI:  http://dx.doi.org/10.18535/jmscr/v4i7.16

Abstract

Background and Objective: Cardiovascular deaths and disorders have increased at a fast rate in low and middle-income countries. In India most of population pays their healthcare bills out of their own pocket, so there is always a need to reduce the economic burden on the patients. The research was conducted to implement and analyze “Advance Patients Care Plan” for cardiovascular disorders and its impact in terms of patient therapeutic outcomes.

Methods: In this single blinded double arm interventional research three different strategic interventions were implemented under “Advance Patients Care Plan” namely Cost minimization by prescribing cheap brands/generics, Early ADR detection & prevention and Life style modifications. The outcomes were recorded in terms of patient’s therapeutic outcomes, quality of life and reduction in economic burden. The data was analyzed statistically.

Results: The overall mean score of WHO QoL BREF questionnaire of experimental group was 58.2±8.65 which was comparatively higher than 45.95±1.08 of control group. The overall mean MLHFQ score was 38.33±6.98 and 65.67±3.75 for experimental group and control group respectively. The total cumulative therapy cost was accounted ₹ 240660 in Experimental Group whereas patients in Control Group spend ₹ 319114.80 on therapy. The Implemented ‘‘Advance Patients Care Plan’’ reduced total cost for therapy by ₹ 2615.16 for each patient.

Interpretation and Conclusions: Advance Patients Care Plan in addition to treatment showed significant evidence in improvement of patients’ therapeutic outcomes, improved quality of life and reduced economic burden on the patients.

Key words: Pharmacoeconomics, Advance Patients Care Plan, Therapeutic outcome, Quality of Life, Therapy, cost 

References

    

1.      Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; Fuster V, Kelly BB, editors. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington (DC): National Academies Press (US); 2010. 2, Epidemiology of Cardiovascular Disease.

2.      Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007; 370: 2054-62.

3.      McGill HC, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 2008; 117: 1216–27.

4.      Gaziano A, Bitton A, Anand S, Abrahams S, Murphy A. Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries. Current problems in cardiology 2010;35: 72-115.

5.      Paneth N, M. Susser.Early origin of coronary heart disease (the" Barker hypothesis"). BMJ: British Medical Journal 1995; 310: 411.

6.      Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. The Lancet 1997; 349: 1436-42.

7.      Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. The Lancet 2002; 360: 1347-60.

8.      Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine 2006;3:e442.

9.      Naveiro-Rilo JC, Diez-Juárez DM, Blanco  AR, Rebollo-Gutiérrez F, Rodríguez-Martínez A, Rodríguez-García M A. Validation of the Minnesota living with heart failure questionnaire in primary care. Rev Esp Cardiol 2010; 63:1419-1427.

10.  Rector TS, Kubo SH, Cohn, JN.Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993;71:1106-1107.

11.  Skevington SM., Lotfy M, O'Connell K A. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of life Research 2004; 13: 299-310.

12.  Bhojani U, Thriveni B, Devadasan R, Munegowda C, Devadasan N, Kolsteren Pet al. Out-of-pocket healthcare payments on chronic conditions impoverish urban poor in Bangalore, India. BMC Public Health 2012;1: 990.

Corresponding Author

Dr Soumadip Das

Assistant Professor

MLR Institute of Pharmacy, Hyderabad, Telengana